The effect of Dexmethomedin on oxygenatio
Phase 2
- Conditions
- Drug effect on lung ventilation.Intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified
- Registration Number
- IRCT201610174731N15
- Lead Sponsor
- Tabriz Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Class I or III according to ASA classification; aged between 18 to 65 year-old; candidate for elective thoracotomy with DLV. Exclusion criteria: severe cardiac disease; severe hepatic disease; severe renal disease; body mass index greater than 30; anemia (hemoglobin less than 12mg / dl ); chest trauma; sensitivity to dexmetedomidin
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluating dexmetedomidine effects on arterial oxygenation. Timepoint: 10 minutes after anesthesia and 20 minutes before end of the operation. Method of measurement: arterial blood oxygen saturation measurement.
- Secondary Outcome Measures
Name Time Method Measurement the use of other anesthetic agents during dexmetedomidine administration. Timepoint: during operation. Method of measurement: measuring dosage of anesthetic agents administered other than dexmetedomidine.